Dimerix Home
  • Dimerix Bioscience
  • About Dimerix
    • Brief History
    • Board of Directors
    • Management
  • Dimerix Platform
    • GPCR-HIT Configuration
    • GPCR Drug Discovery
    • Publications
  • Dimerix Programs
    • Therapeutic Programs
    • Development Partnerships
  • Newsroom
    • News Articles / Press Releases
    • Links
  • Contact

Dimerix Programs

  • Therapeutic Programs
  • Development Partnerships

  • Recent News Articles

    • Dimerix’s CSO, A/Prof. Kevin Pfleger, Awarded the 2011 3M Eureka Prize for Emerging Leader in Science
    • New Board Appointment – Dr Mark Ashton
    • Conference Attendance: Miptec: 19-22 September 2011, Basel, Switzerland
    • Dimerix Chief Scientific Officer Shortlisted for Australian Museum ‘Eureka Prize’
    • Conference Attendance: ELRIG: Fifth Annual Drug Discovery Conference, 7-8 September 2011, Manchester, UK
    • Conference Attendance: BIO International Convention 2011 – Washington D.C.
    • Conference Presentation: Australian Biotech on Show Life Science Investment Showcase – New York
    • Takeda Cambridge in Second Deal to Expand Use of Dimerix’s GPCR-HIT Platform

  • Subscribe

    • Read the Dimerix Bioscience Blog
    • Subscribe via RSS RSS icon
    • or, subscribe via email:

  • News Article Categories

    • News
    • Press Release

Powered by OM4 Business Websites | Log in